DISCONTINUED OPERATIONS (TABLES)

12 Months Ended

Dec. 31, 2011

Notes To Consolidated Financial Statement Abstract

Schedule Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures Text Block

	YEARS ENDED DECEMBER 31,
	2011		2010		2009
Net revenues	$	540	$	4,037	$	1,268
Cost of revenues		2,553		3,124		739
Gross profit		(2,013)		913		529
Operating expenses:
Selling, general and administrative		15,752		18,006		15,462
Research and development		8,978		14,038		14,215
Depreciation and amortization		-		1,275		1,160
Impairment of long-lived assets		-		9,791		-
Operating loss		(26,743)		(42,197)		(30,308)
Gain on sale to Solta		(27,934)		-		-
Gain (loss) from discontinued operations
before income tax benefit		1,191		(42,197)		(30,308)
Income tax benefit		(18,392)		(15,149)		(11,513)
Gain (loss) from discontinued operations,
net of income tax benefit	$	19,583	$	(27,048)	$	(18,795)

	DECEMBER 31, 2010
Cash and cash equivalents	$	629
Accounts receivable, net		129
Inventories, net		4,495
Deferred tax assets, net		7,328
Other assets		546
Assets held for sale from discontinued operations	$	13,127
Accounts payable	$	1,802
Other liabilities		5,474
Liabilities held for sale from discontinued operations	$	7,276

	YEAR ENDED DECEMBER 31,
	2011		2010		2009
Gain (loss) from discontinued operations, net of income tax benefit	$	19,583	$	(27,048)	$	(18,795)
Gain on sale of LipoSonix		(27,934)		-		-
Depreciation and amortization		-		1,275		1,160
Share-based compensation expense		(166)		1,304		1,179
Impairment of long-lived assets		-		9,791		-
Decrease in assets held for sale from discontinued operations		7,073		2,267		3,869
(Decrease) increase in liabilities held for sale from discontinued operations		(6,343)		39		1,626
Net cash used in operating activities from
discontinued operations	$	(7,787)	$	(12,372)	$	(10,961)